Cargando…
DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone
Chronic pediatric inflammatory bowel disease (IBD) leads to lack of bone accrual, bone loss, and increased fractures. Presently there is no cure, and many IBD treatments incur negative side effects. We previously discovered treatment with exogenous irisin resolved inflammatory changes in the colon,...
Autores principales: | Metzger, Corinne E., Narayanan, S. Anand, Elizondo, Jon P., Carter, Anne Michal, Zawieja, David C., Hogan, Harry A., Bloomfield, Susan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805923/ https://www.ncbi.nlm.nih.gov/pubmed/31641205 http://dx.doi.org/10.1038/s41598-019-51550-w |
Ejemplares similares
-
Hindlimb unloading causes regional loading-dependent changes in osteocyte inflammatory cytokines that are modulated by exogenous irisin treatment
por: Metzger, Corinne E., et al.
Publicado: (2020) -
Sulforaphane alter the microbiota and mitigate colitis severity on mice ulcerative colitis induced by DSS
por: Zhang, Yan, et al.
Publicado: (2020) -
Delayed and limited administration of the JAKinib tofacitinib mitigates chronic DSS-induced colitis
por: Seal, Rishav, et al.
Publicado: (2023) -
Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism
por: Zhang, Jin, et al.
Publicado: (2017) -
The Anti-Inflammatory Activities of Fermented Curcuma That Contains Butyrate Mitigate DSS-Induced Colitis in Mice
por: Bayazid, Al Borhan, et al.
Publicado: (2022)